Baird Maintains Outperform on Thermo Fisher Scientific, Lowers Price Target to $622
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Catherine Schulte maintains an Outperform rating on Thermo Fisher Scientific (NYSE:TMO) but lowers the price target from $632 to $622.

October 24, 2024 | 11:38 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Baird analyst Catherine Schulte maintains an Outperform rating on Thermo Fisher Scientific but lowers the price target from $632 to $622.
The Outperform rating suggests continued confidence in TMO's performance, but the lowered price target indicates a slight reduction in expected upside. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100